Total Funding
1
Total FundingGrant raised
Growth Score in past quarter
pts
Heat Score 1 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2081536
Jade Therapeutics develops locally administered, polymer-based products designed to treat poorly-served ophthalmic indications.
- Stephen From: President & CEO
About the Company
Jade Therapeutics develops ophthalmic sustained-release drug delivery platforms. The company focuses on the development of locally administered, sustained-release therapeutics that improve corneal healing following damage from disease or injury and improve visual function and quality of life. Its product delivers recombinant human growth hormone, a
well-characterized biologic, that has healing properties via the activation and recruitment of key cells involved in the tissue-building process.
Women Founded


